Important Notice for Boston Scientific Shareholders: Class Action Lawsuit Details

Boston Scientific Shareholder Alert

The Gross Law Firm recently released an urgent notice for shareholders of Boston Scientific Corporation (NYSE: BSX). This advisory is particularly significant for those who acquired shares during the specified class period, from July 23, 2025, to February 3, 2026. Those affected are encouraged to reach out to inquire about their potential eligibility to be appointed as lead plaintiffs in the ongoing class action lawsuit. Notably, it’s important to clarify that registration as lead plaintiff is not a prerequisite for participation in any financial recovery stemming from this case.

Allegations Overview

The lawsuit arises from allegations that Boston Scientific made excessively positive claims to investors, while simultaneously concealing critical unfavorable information about the conditions within their U.S. Electrophysiology (EP) segment. Specifically, the complaint suggests that the company's management was aware that the growth rate of this segment was not sustainable and that it was nearing a tipping point sooner than analysts had predicted. Despite earlier claims of a thriving EP business, management faced scrutiny when the actual performance failed to meet the elevated expectations articulated to investors.

Following the company's announcement of its fourth-quarter and full-year results for 2025 on February 4, 2026, Boston Scientific reported disappointing sales figures and gave guidance that was significantly below market expectations. Highlighting the rapid deterioration in stock value, shares of Boston Scientific sunk from a closing market price of $91.62 the previous day to $75.50 on the day of the announcement—a staggering drop of around 17.6% within just 24 hours.

Registration Details

The deadline for affected shareholders to register for this class action is May 4, 2026. Interested individuals can connect with the Gross Law Firm to get additional details and complete their registration by filling out the following loss submission form.

Upon registering as a shareholder within the specified timeframe, participants will be provided with monitoring software designed to keep them updated on the case's progress. It's crucial for shareholders to act promptly to secure their positions in this lawsuit.

Why Choose Gross Law Firm?

The Gross Law Firm is renowned for its commitment to safeguarding investor rights, particularly for those who have suffered losses due to fraudulent corporate practices. Their mission focuses on holding companies accountable for their actions and ensuring transparent business conduct. The firm’s legal expertise is essential in pursuing recoveries for investors misled by false or misleading corporate disclosures.

For further inquiries, individuals can contact the Gross Law Firm at: 15 West 38th Street, 12th Floor, New York, NY, 10018, or via phone at (646) 453-8903. Shareholders should be aware that participating in the case incurs no costs and is not obligatory to recover potential losses.

With the complex landscape of securities fraud, it’s vital for affected shareholders of Boston Scientific to remain informed and proactive. Engage with resources and consider your options to ensure your rights and investments are protected.